IOL CHEMICALS & PHARM. | MEDICO REMEDIES | IOL CHEMICALS & PHARM./ MEDICO REMEDIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 57.1 | 23.0% | View Chart |
P/BV | x | 1.5 | 9.1 | 16.5% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. MEDICO REMEDIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
MEDICO REMEDIES Mar-23 |
IOL CHEMICALS & PHARM./ MEDICO REMEDIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 87 | 617.3% | |
Low | Rs | 272 | 16 | 1,701.3% | |
Sales per share (Unadj.) | Rs | 377.6 | 16.9 | 2,231.3% | |
Earnings per share (Unadj.) | Rs | 23.7 | 0.9 | 2,715.5% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 1.2 | 2,629.0% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 5.3 | 4,860.5% | |
Shares outstanding (eoy) | m | 58.71 | 82.98 | 70.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 3.0 | 35.2% | |
Avg P/E ratio | x | 17.1 | 59.0 | 28.9% | |
P/CF ratio (eoy) | x | 12.8 | 42.9 | 29.9% | |
Price / Book Value ratio | x | 1.6 | 9.7 | 16.2% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 4,272 | 555.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 57 | 2,961.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 1,404 | 1,578.7% | |
Other income | Rs m | 256 | 41 | 626.9% | |
Total revenues | Rs m | 22,427 | 1,445 | 1,551.8% | |
Gross profit | Rs m | 2,257 | 95 | 2,380.2% | |
Depreciation | Rs m | 462 | 27 | 1,696.4% | |
Interest | Rs m | 165 | 7 | 2,204.8% | |
Profit before tax | Rs m | 1,887 | 101 | 1,868.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 29 | 1,732.9% | |
Profit after tax | Rs m | 1,391 | 72 | 1,921.3% | |
Gross profit margin | % | 10.2 | 6.8 | 150.8% | |
Effective tax rate | % | 26.2 | 28.3 | 92.8% | |
Net profit margin | % | 6.3 | 5.2 | 121.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 662 | 1,460.9% | |
Current liabilities | Rs m | 5,025 | 432 | 1,164.5% | |
Net working cap to sales | % | 20.9 | 16.4 | 127.7% | |
Current ratio | x | 1.9 | 1.5 | 125.5% | |
Inventory Days | Days | 43 | 3 | 1,649.8% | |
Debtors Days | Days | 8 | 938 | 0.9% | |
Net fixed assets | Rs m | 11,017 | 229 | 4,809.2% | |
Share capital | Rs m | 587 | 166 | 353.7% | |
"Free" reserves | Rs m | 14,490 | 272 | 5,318.2% | |
Net worth | Rs m | 15,077 | 438 | 3,438.9% | |
Long term debt | Rs m | 0 | 2 | 0.0% | |
Total assets | Rs m | 20,684 | 891 | 2,322.0% | |
Interest coverage | x | 12.5 | 14.5 | 85.8% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.6 | 68.0% | |
Return on assets | % | 7.5 | 9.0 | 83.9% | |
Return on equity | % | 9.2 | 16.5 | 55.9% | |
Return on capital | % | 13.6 | 24.6 | 55.3% | |
Exports to sales | % | 26.7 | 88.0 | 30.4% | |
Imports to sales | % | 0 | 8.6 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 1,236 | 479.6% | |
Imports (cif) | Rs m | NA | 121 | 0.0% | |
Fx inflow | Rs m | 5,930 | 1,236 | 479.6% | |
Fx outflow | Rs m | 6,052 | 124 | 4,865.2% | |
Net fx | Rs m | -122 | 1,112 | -10.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 82 | 1,497.1% | |
From Investments | Rs m | -1,200 | -66 | 1,817.1% | |
From Financial Activity | Rs m | -41 | -18 | 226.2% | |
Net Cashflow | Rs m | -18 | -3 | 724.4% |
Indian Promoters | % | 48.2 | 73.3 | 65.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 1.0 | 165.0% | |
FIIs | % | 1.4 | 0.3 | 482.8% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 26.7 | 194.3% | |
Shareholders | 130,003 | 10,685 | 1,216.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | MEDICO REMEDIES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.18% | -1.18% | -0.44% |
1-Month | -4.51% | -35.72% | 2.15% |
1-Year | -4.09% | -39.22% | 49.82% |
3-Year CAGR | -12.01% | 106.32% | 14.21% |
5-Year CAGR | 15.35% | 61.21% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the MEDICO REMEDIES share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of MEDICO REMEDIES the stake stands at 73.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of MEDICO REMEDIES .
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
MEDICO REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of MEDICO REMEDIES .
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.